Literature DB >> 10092270

Changing perceptions in osteoporosis.

T J Wilkin1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10092270      PMCID： PMC1115284          DOI： 10.1136/bmj.318.7187.862

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  20 in total

1.  Bone density and risk of hip fracture in men and women: cross sectional analysis.

Authors:  C E De Laet; B A van Hout; H Burger; A Hofman; H A Pols
Journal:  BMJ       Date:  1997-07-26

Review 2.  Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.

Authors:  B L Riggs; L J Melton; W M O'Fallon
Journal:  Bone       Date:  1996-03       Impact factor: 4.398

3.  The value of biochemical markers of bone turnover in osteoporosis.

Authors:  R Eastell; A Blumsohn
Journal:  J Rheumatol       Date:  1997-06       Impact factor: 4.666

4.  Calcium intake and fracture risk: results from the study of osteoporotic fractures.

Authors:  R G Cumming; S R Cummings; M C Nevitt; J Scott; K E Ensrud; T M Vogt; K Fox
Journal:  Am J Epidemiol       Date:  1997-05-15       Impact factor: 4.897

Review 5.  ABC of rheumatology. Osteoporosis.

Authors:  N Peel; R Eastell
Journal:  BMJ       Date:  1995-04-15

6.  Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.

Authors:  R Lindsay; J Nieves; C Formica; E Henneman; L Woelfert; V Shen; D Dempster; F Cosman
Journal:  Lancet       Date:  1997-08-23       Impact factor: 79.321

7.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Authors:  D M Black; S R Cummings; D B Karpf; J A Cauley; D E Thompson; M C Nevitt; D C Bauer; H K Genant; W L Haskell; R Marcus; S M Ott; J C Torner; S A Quandt; T F Reiss; K E Ensrud
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321

8.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

9.  Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Authors:  P Garnero; W J Shih; E Gineyts; D B Karpf; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

10.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

Authors:  D Marshall; O Johnell; H Wedel
Journal:  BMJ       Date:  1996-05-18
View more
  12 in total

1.  Changing perceptions in osteoporosis. Several risk factors are important.

Authors:  C W McGrother; M M Donaldson
Journal:  BMJ       Date:  1999-11-20

2.  Selling sickness: the pharmaceutical industry and disease mongering.

Authors:  Ray Moynihan; Iona Heath; David Henry
Journal:  BMJ       Date:  2002-04-13

3.  Bone densitometry is not a good predictor of hip fracture.

Authors:  T J Wilkin; D Devendra
Journal:  BMJ       Date:  2001-10-06

4.  The pharmaceutical industry and disease mongering. The industry works to develop drugs, not diseases.

Authors:  Richard Tiner
Journal:  BMJ       Date:  2002-07-27

5.  Novel experimental effects on bone material properties and the pre- and postyield behavior of bones may be independent of bone mineralization.

Authors:  Gustavo R Cointry; Ricardo F Capozza; María A Chiappe; Sara Feldman; Margarita D Meta; Stella M Daniele; Néstor M Fracalossi; Paola Reina; José L Ferretti
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

6.  Risk of fracture in celiac disease: gender, dietary compliance, or both?

Authors:  María Inés Pinto Sánchez; Adriana Mohaidle; Andrea Baistrocchi; Dolores Matoso; Horacio Vázquez; Andrea González; Roberto Mazure; Evangelina Maffei; Guillermina Ferrari; Edgardo Smecuol; Adriana Crivelli; Juan Andrés de Paula; Juan C Gómez; Silvia Pedreira; Eduardo Mauriño; Julio César Bai
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

7.  The relationship between vitamin D receptor (VDR) polymorphism and the occurrence of osteoporosis in menopausal Iranian women.

Authors:  Raheleh Dabirnia; Sanaz Mahmazi; Amirhossein Taromchi; Masoum Nikzad; Ehsan Saburi
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

8.  Absorptiometric assessment of muscle-bone relationships in humans: reference, validation, and application studies.

Authors:  Gustavo R Cointry; Ricardo F Capozza; Sebastián E Ferretti; Margarita D Meta; Sara Feldman; Ricardo Capiglioni; Paola Reina; Néstor M Fracalossi; María R Ulla; Carlos Cure-Cure; José L Ferretti
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

9.  Updated recommendations for the diagnosis and management of osteoporosis: a local perspective.

Authors:  Hussein Raef; Munira Al-Bugami; Sakra Balharith; Mahmoud Moawad; Mohammad El-Shaker; Anita Hassan; Ahmad Al-Shaikh; Ismail Al-Badawi
Journal:  Ann Saudi Med       Date:  2011 Mar-Apr       Impact factor: 1.526

Review 10.  Mechanical basis of bone strength: influence of bone material, bone structure and muscle action.

Authors:  N H Hart; S Nimphius; T Rantalainen; A Ireland; A Siafarikas; R U Newton
Journal:  J Musculoskelet Neuronal Interact       Date:  2017-09-01       Impact factor: 2.041
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.